PT Medikaloka Hermina TbkISX:HEAL -2.84%72 Operating Margin % is 12.10% as of Mar. 2026, which is 15% below its 10-year median of 14.18. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,574.99 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 76.2% on this metric.
PT Medikaloka Hermina Tbk operating margin has been in a 5-year decline. The average rate of decline per year is -11.4%.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Operating Margin % or its related term are showing as below:
ISX:HEAL'
s Operating Margin % Range Over the Past 10 Years
Min: 10.53 Med: 14.18 Max: 29.57
Current: 12.47
ISX:HEAL's Operating Margin % is ranked better than 76.2% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs ISX:HEAL: 12.47
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
PT Medikaloka Hermina Tbk Operating Margin % Related Terms
PT Medikaloka Hermina Tbk Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Operating Margin % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
PT Medikaloka Hermina Tbk's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Operating Margin % of 12.10% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 15% below median its historical median of 14.18. Over the past decade, PT Medikaloka Hermina Tbk's Operating Margin % has ranged from 10.53 to 29.57. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #159 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 23.8%.
Is PT Medikaloka Hermina Tbk's Operating Margin % too high?
PT Medikaloka Hermina Tbk's current Operating Margin % of 12.10% is 15% below median its 10-year median of 14.18. Over the past 10 years, this metric has ranged from a low of 10.53 to a high of 29.57. The Healthcare Providers & Services industry median Operating Margin % is 4.85. PT Medikaloka Hermina Tbk's value of 12.10% is 149.7% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #159 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #159 out of 668 companies for Operating Margin %. This places PT Medikaloka Hermina Tbk in the top 24% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.85. PT Medikaloka Hermina Tbk's value of 12.10% is 149.7% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own Operating Margin % has ranged from 10.53 to 29.57 over the past decade. While the company's 10-year median is 14.18 vs. the industry median of 4.85, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Operating Margin % of 12.10% is 149.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Operating Margin % is 12.10%, which is 15% below median its own 10-year median of 14.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,574.99, compared to a current price of Rp855.00 — trading 45.7% below its estimated fair value. The current Operating Margin % is 12.10%, which is 15% below median its 10-year median of 14.18 and 149.7% above the Healthcare Providers & Services industry median of 4.85. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Operating Margin % is 12.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp855.00 is trading 45.7% below its estimated GF Value™ of Rp1,574.99.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Operating Margin %: 12.10% (15% below median its 10-year median of 14.18)
GF Value™: Rp1,574.99 vs. price of Rp855.00 (45.7% below fair value)
Industry Position: 149.7% above the Healthcare Providers & Services median (#159 of 668)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
